ID   LDB3_MOUSE              Reviewed;         723 AA.
AC   Q9JKS4; B2RSB0; B7ZNT6; Q6A038; Q811P2; Q811P3; Q811P4; Q811P5; Q9D130;
AC   Q9JKS3; Q9R0Z1; Q9WVH1; Q9WVH2;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   07-APR-2021, entry version 159.
DE   RecName: Full=LIM domain-binding protein 3;
DE   AltName: Full=Protein cypher;
DE   AltName: Full=Protein oracle;
DE   AltName: Full=Z-band alternatively spliced PDZ-motif protein;
GN   Name=Ldb3 {ECO:0000312|MGI:MGI:1344412}; Synonyms=Kiaa0613;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAD42950.2}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 6), INTERACTION WITH ACTN2 AND
RP   PKC, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=NIH Swiss {ECO:0000312|EMBL:AAD42950.2};
RC   TISSUE=Heart {ECO:0000312|EMBL:AAD42950.2}, and
RC   Skeletal muscle {ECO:0000312|EMBL:AAD42951.2};
RX   PubMed=10391924; DOI=10.1074/jbc.274.28.19807;
RA   Zhou Q., Ruiz-Lozano P., Martone M.E., Chen J.;
RT   "Cypher, a striated muscle-restricted PDZ and LIM domain-containing
RT   protein, binds to alpha-actinin-2 and protein kinase C.";
RL   J. Biol. Chem. 274:19807-19813(1999).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CAB46747.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), AND TISSUE SPECIFICITY.
RC   TISSUE=Diaphragm {ECO:0000312|EMBL:CAB46747.1};
RX   PubMed=10427098; DOI=10.1083/jcb.146.2.465;
RA   Faulkner G., Pallavicini A., Formentin E., Comelli A., Ievolella C.,
RA   Trevisan S., Bortoletto G., Scannapieco P., Salamon M., Mouly V., Valle G.,
RA   Lanfranchi G.;
RT   "ZASP: a new Z-band alternatively spliced PDZ-motif protein.";
RL   J. Cell Biol. 146:465-475(1999).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAF33847.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), AND TISSUE SPECIFICITY.
RC   TISSUE=Heart {ECO:0000312|EMBL:AAF33847.1};
RX   PubMed=10727866; DOI=10.1016/s0925-4773(99)00330-5;
RA   Passier R., Richardson J.A., Olson E.N.;
RT   "Oracle, a novel PDZ-LIM domain protein expressed in heart and skeletal
RT   muscle.";
RL   Mech. Dev. 92:277-284(2000).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAO26189.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 5), TISSUE SPECIFICITY,
RP   AND DEVELOPMENTAL STAGE.
RC   STRAIN=NIH Swiss {ECO:0000312|EMBL:AAO26189.1};
RC   TISSUE=Heart {ECO:0000312|EMBL:AAO26188.1}, and
RC   Skeletal muscle {ECO:0000312|EMBL:AAO26189.1};
RX   PubMed=12499364; DOI=10.1074/jbc.m211875200;
RA   Huang C., Zhou Q., Liang P., Hollander M.S., Sheikh F., Li X., Greaser M.,
RA   Shelton G.D., Evans S., Chen J.;
RT   "Characterization and in vivo functional analysis of splice variants of
RT   cypher.";
RL   J. Biol. Chem. 278:7360-7365(2003).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:BAD32258.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain {ECO:0000312|EMBL:BAD32258.1};
RX   PubMed=15368895; DOI=10.1093/dnares/11.3.205;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Seino S., Nishimura M., Kaisho T., Hoshino K., Kitamura H.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: IV.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 11:205-218(2004).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:BAE25016.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-145.
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAE25016.1};
RC   TISSUE=Embryo, Heart {ECO:0000312|EMBL:BAE25016.1}, and
RC   Urinary bladder {ECO:0000312|EMBL:BAE23262.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [7] {ECO:0000305, ECO:0000312|EMBL:AAH99596.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 6).
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:AAH99596.1};
RC   TISSUE=Lung, and Mammary gland {ECO:0000312|EMBL:AAH99596.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-98; THR-119; SER-121;
RP   SER-123; SER-214; SER-220 AND SER-251, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-112 (ISOFORMS 2; 4 AND 6), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-327 (ISOFORM 5), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT
RP   SER-288 (ISOFORM 6), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Kidney, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-216; ARG-512 AND ARG-529,
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-330 (ISOFORM 3), METHYLATION
RP   [LARGE SCALE ANALYSIS] AT ARG-291 (ISOFORM 4), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [10]
RP   STRUCTURE BY NMR OF 1-83.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of PDZ domain of mouse cypher protein.";
RL   Submitted (MAY-2004) to the PDB data bank.
CC   -!- FUNCTION: May function as an adapter in striated muscle to couple
CC       protein kinase C-mediated signaling via its LIM domains to the
CC       cytoskeleton. {ECO:0000303|PubMed:10391924}.
CC   -!- SUBUNIT: Interacts via its LIM domains with various PKC isoforms.
CC       Interacts via its PDZ domain with the ACTN2 C-terminal region.
CC       Interacts with MYOZ1, MYOZ2 and MYOZ3. {ECO:0000250|UniProtKB:O75112,
CC       ECO:0000269|PubMed:10391924}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:10391924}. Cell projection, pseudopodium
CC       {ECO:0000269|PubMed:10391924}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:10391924}. Cytoplasm, myofibril, sarcomere, Z line
CC       {ECO:0000269|PubMed:10391924}. Note=Localized to the cytoplasm around
CC       nuclei and pseudopodia of undifferentiated cells and detected
CC       throughout the myotubes of differentiated cells. Colocalizes with ACTN2
CC       at the Z-lines.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1 {ECO:0000269|PubMed:10391924}; Synonyms=Cypher1c
CC       {ECO:0000303|PubMed:12499364}, Oracle 1 {ECO:0000303|PubMed:10727866};
CC         IsoId=Q9JKS4-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:12499364}; Synonyms=Cypher1s
CC       {ECO:0000303|PubMed:12499364};
CC         IsoId=Q9JKS4-2; Sequence=VSP_051903;
CC       Name=3 {ECO:0000269|PubMed:10427098, ECO:0000269|PubMed:12499364};
CC       Synonyms=Cypher3c {ECO:0000303|PubMed:12499364}, Oracle 2
CC       {ECO:0000303|PubMed:10727866};
CC         IsoId=Q9JKS4-3; Sequence=VSP_051904;
CC       Name=4 {ECO:0000269|PubMed:12499364}; Synonyms=Cypher3s
CC       {ECO:0000303|PubMed:12499364};
CC         IsoId=Q9JKS4-4; Sequence=VSP_051903, VSP_051904;
CC       Name=5 {ECO:0000269|PubMed:12499364}; Synonyms=Cypher2c
CC       {ECO:0000303|PubMed:12499364};
CC         IsoId=Q9JKS4-5; Sequence=VSP_051905, VSP_051906;
CC       Name=6 {ECO:0000269|PubMed:10391924, ECO:0000269|PubMed:10427098};
CC       Synonyms=Cypher2s {ECO:0000303|PubMed:12499364};
CC         IsoId=Q9JKS4-6; Sequence=VSP_051903, VSP_051905, VSP_051906;
CC   -!- TISSUE SPECIFICITY: Expressed primarily in adult heart and skeletal
CC       muscle, and detected at lower levels in lung. Isoforms are expressed in
CC       a tissue-specific manner. Isoform 1, isoform 3 and isoform 5 are
CC       expressed in heart, whereas isoform 2, isoform 4 and isoform 6 are
CC       expressed in skeletal muscle. {ECO:0000269|PubMed:10391924,
CC       ECO:0000269|PubMed:10427098, ECO:0000269|PubMed:10727866,
CC       ECO:0000269|PubMed:12499364}.
CC   -!- DEVELOPMENTAL STAGE: Initially expressed in a myocardium-specific
CC       manner at 8.5-9 dpc and remains cardiac-restricted until day 12.
CC       Strongly expressed throughout heart in all stages examined. At 12.5 dpc
CC       expressed at low levels in non-cardiac striated muscles. By 14.5 dpc
CC       expressed at high levels in both cardiac and skeletal muscle, and also
CC       strongly expressed in striated muscles of tongue, thoracic and
CC       abdominal muscles, leg and diaphragm. The various isoforms are
CC       developmentally regulated in both skeletal and cardiac muscle. Isoform
CC       5 and isoform 6, which are barely detectable during embryogenesis are
CC       up-regulated postnatally. In heart, isoform 3 is up-regulated
CC       developmentally, whereas the predominant isoform 1 is expressed
CC       throughout development and into adulthood. In skeletal muscle, the
CC       predominant isoform 2 is gradually replaced by isoform 4 postnatally.
CC       {ECO:0000269|PubMed:10391924, ECO:0000269|PubMed:12499364}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB23128.1; Type=Miscellaneous discrepancy; Note=Sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=BAD32258.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF114378; AAD42950.2; -; mRNA.
DR   EMBL; AF114379; AAD42951.2; -; mRNA.
DR   EMBL; AJ005621; CAB46747.1; -; mRNA.
DR   EMBL; AF228057; AAF33847.1; -; mRNA.
DR   EMBL; AF228058; AAF33848.1; -; mRNA.
DR   EMBL; AY206011; AAO26187.1; -; mRNA.
DR   EMBL; AY206012; AAO26188.1; -; mRNA.
DR   EMBL; AY206013; AAO26189.1; -; mRNA.
DR   EMBL; AY206015; AAO26190.1; -; mRNA.
DR   EMBL; AK172980; BAD32258.1; ALT_INIT; mRNA.
DR   EMBL; AK004020; BAB23128.1; ALT_SEQ; mRNA.
DR   EMBL; AK137181; BAE23262.1; -; mRNA.
DR   EMBL; AK142292; BAE25016.1; -; mRNA.
DR   EMBL; BC099596; AAH99596.1; -; mRNA.
DR   EMBL; BC138793; AAI38794.1; -; mRNA.
DR   EMBL; BC145420; AAI45421.1; -; mRNA.
DR   CCDS; CCDS26940.1; -. [Q9JKS4-3]
DR   CCDS; CCDS26941.1; -. [Q9JKS4-1]
DR   CCDS; CCDS26942.1; -. [Q9JKS4-5]
DR   CCDS; CCDS36879.1; -. [Q9JKS4-2]
DR   CCDS; CCDS88626.1; -. [Q9JKS4-4]
DR   CCDS; CCDS88627.1; -. [Q9JKS4-6]
DR   RefSeq; NP_001034160.1; NM_001039071.2. [Q9JKS4-3]
DR   RefSeq; NP_001034161.1; NM_001039072.2.
DR   RefSeq; NP_001034162.1; NM_001039073.2. [Q9JKS4-4]
DR   RefSeq; NP_001034163.1; NM_001039074.2. [Q9JKS4-2]
DR   RefSeq; NP_001034164.1; NM_001039075.2. [Q9JKS4-6]
DR   RefSeq; NP_001034165.1; NM_001039076.2. [Q9JKS4-5]
DR   RefSeq; NP_036048.3; NM_011918.4. [Q9JKS4-1]
DR   RefSeq; XP_006519080.1; XM_006519017.3. [Q9JKS4-2]
DR   RefSeq; XP_017171508.1; XM_017316019.1. [Q9JKS4-1]
DR   PDB; 1WJL; NMR; -; A=1-83.
DR   PDBsum; 1WJL; -.
DR   BMRB; Q9JKS4; -.
DR   SMR; Q9JKS4; -.
DR   BioGRID; 204912; 17.
DR   IntAct; Q9JKS4; 4.
DR   MINT; Q9JKS4; -.
DR   STRING; 10090.ENSMUSP00000022327; -.
DR   iPTMnet; Q9JKS4; -.
DR   PhosphoSitePlus; Q9JKS4; -.
DR   PaxDb; Q9JKS4; -.
DR   PeptideAtlas; Q9JKS4; -.
DR   PRIDE; Q9JKS4; -.
DR   ProteomicsDB; 264925; -. [Q9JKS4-1]
DR   ProteomicsDB; 264926; -. [Q9JKS4-2]
DR   ProteomicsDB; 264927; -. [Q9JKS4-3]
DR   ProteomicsDB; 264928; -. [Q9JKS4-4]
DR   ProteomicsDB; 264929; -. [Q9JKS4-5]
DR   ProteomicsDB; 264930; -. [Q9JKS4-6]
DR   Antibodypedia; 15974; 254 antibodies.
DR   Ensembl; ENSMUST00000022327; ENSMUSP00000022327; ENSMUSG00000021798. [Q9JKS4-1]
DR   Ensembl; ENSMUST00000022328; ENSMUSP00000022328; ENSMUSG00000021798. [Q9JKS4-3]
DR   Ensembl; ENSMUST00000022330; ENSMUSP00000022330; ENSMUSG00000021798. [Q9JKS4-5]
DR   Ensembl; ENSMUST00000090040; ENSMUSP00000087494; ENSMUSG00000021798. [Q9JKS4-2]
DR   Ensembl; ENSMUST00000227819; ENSMUSP00000154119; ENSMUSG00000021798. [Q9JKS4-6]
DR   Ensembl; ENSMUST00000228044; ENSMUSP00000154758; ENSMUSG00000021798. [Q9JKS4-4]
DR   GeneID; 24131; -.
DR   KEGG; mmu:24131; -.
DR   UCSC; uc007taz.1; mouse. [Q9JKS4-2]
DR   UCSC; uc007tba.1; mouse. [Q9JKS4-4]
DR   UCSC; uc007tbc.1; mouse. [Q9JKS4-1]
DR   UCSC; uc007tbd.1; mouse. [Q9JKS4-3]
DR   UCSC; uc007tbe.1; mouse. [Q9JKS4-6]
DR   UCSC; uc007tbf.1; mouse. [Q9JKS4-5]
DR   CTD; 11155; -.
DR   MGI; MGI:1344412; Ldb3.
DR   eggNOG; KOG1703; Eukaryota.
DR   GeneTree; ENSGT00940000154877; -.
DR   HOGENOM; CLU_038114_0_0_1; -.
DR   InParanoid; Q9JKS4; -.
DR   OMA; SNVYCER; -.
DR   OrthoDB; 1013114at2759; -.
DR   PhylomeDB; Q9JKS4; -.
DR   TreeFam; TF106408; -.
DR   BioGRID-ORCS; 24131; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Ldb3; mouse.
DR   EvolutionaryTrace; Q9JKS4; -.
DR   PRO; PR:Q9JKS4; -.
DR   Proteomes; UP000000589; Chromosome 14.
DR   RNAct; Q9JKS4; protein.
DR   Bgee; ENSMUSG00000021798; Expressed in gastrocnemius medialis and 284 other tissues.
DR   ExpressionAtlas; Q9JKS4; baseline and differential.
DR   Genevisible; Q9JKS4; MM.
DR   GO; GO:0005912; C:adherens junction; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0031941; C:filamentous actin; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0031143; C:pseudopodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0001725; C:stress fiber; IBA:GO_Central.
DR   GO; GO:0030018; C:Z disc; IDA:MGI.
DR   GO; GO:0003779; F:actin binding; IBA:GO_Central.
DR   GO; GO:0008092; F:cytoskeletal protein binding; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051371; F:muscle alpha-actinin binding; IDA:MGI.
DR   GO; GO:0005080; F:protein kinase C binding; IDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0007507; P:heart development; IBA:GO_Central.
DR   GO; GO:0061061; P:muscle structure development; IBA:GO_Central.
DR   GO; GO:0045214; P:sarcomere organization; IMP:MGI.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR031847; DUF4749.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR006643; Zasp-like_motif.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF15936; DUF4749; 1.
DR   Pfam; PF00412; LIM; 3.
DR   Pfam; PF00595; PDZ; 1.
DR   SMART; SM00132; LIM; 3.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00735; ZM; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 3.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection; Cytoplasm;
KW   Cytoskeleton; LIM domain; Metal-binding; Methylation; Phosphoprotein;
KW   Reference proteome; Repeat; Zinc.
FT   CHAIN           1..723
FT                   /note="LIM domain-binding protein 3"
FT                   /id="PRO_0000075768"
FT   DOMAIN          1..84
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          545..603
FT                   /note="LIM zinc-binding 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          604..663
FT                   /note="LIM zinc-binding 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          664..723
FT                   /note="LIM zinc-binding 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         98
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         119
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         121
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         123
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         216
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         251
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         512
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         529
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   VAR_SEQ         108..227
FT                   /note="DPALDTNGSLATPSPSPEARASPGALEFGDTFSSSFSQTSVCSPLMEASGPV
FT                   LPLGSPVAKASSEGAQGSVSPKVLPGPSQPRQYNNPIGLYSAETLREMAQMYQMSLRGK
FT                   ASGAGLLGG -> VVANSPANADYQERFNPSVLKDSALSTHKPIEVKGLGGKATIIHAQ
FT                   YNTPISMYSQDAIMDAIAGQAQAQGSDFSGASPLA (in isoform 2, isoform
FT                   4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10391924,
FT                   ECO:0000303|PubMed:10427098, ECO:0000303|PubMed:12499364,
FT                   ECO:0000303|PubMed:15368895, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_051903"
FT   VAR_SEQ         296..357
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10727866,
FT                   ECO:0000303|PubMed:12499364, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_051904"
FT   VAR_SEQ         296..327
FT                   /note="STPIEHAPVCTSQATSPLLPASAQSPAAASPI -> RERFETERNSPRFAKL
FT                   RNWHHGLSAQILNVKS (in isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10391924,
FT                   ECO:0000303|PubMed:10427098, ECO:0000303|PubMed:12499364,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16141072"
FT                   /id="VSP_051905"
FT   VAR_SEQ         328..723
FT                   /note="Missing (in isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10391924,
FT                   ECO:0000303|PubMed:10427098, ECO:0000303|PubMed:12499364,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16141072"
FT                   /id="VSP_051906"
FT   CONFLICT        108..145
FT                   /note="DPALDTNGSLATPSPSPEARASPGALEFGDTFSSSFSQ -> VVANSPANAD
FT                   YQERFNPSVLKGLSSVLKGLSSVHPQAH (in Ref. 6; BAB23128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        450
FT                   /note="S -> T (in Ref. 1; AAD42950 and 4; AAO26188/
FT                   AAO26189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        512
FT                   /note="R -> W (in Ref. 5; BAD32258)"
FT                   /evidence="ECO:0000305"
FT   STRAND          2..10
FT                   /evidence="ECO:0007744|PDB:1WJL"
FT   STRAND          15..17
FT                   /evidence="ECO:0007744|PDB:1WJL"
FT   TURN            21..24
FT                   /evidence="ECO:0007744|PDB:1WJL"
FT   STRAND          28..32
FT                   /evidence="ECO:0007744|PDB:1WJL"
FT   HELIX           37..40
FT                   /evidence="ECO:0007744|PDB:1WJL"
FT   STRAND          48..54
FT                   /evidence="ECO:0007744|PDB:1WJL"
FT   STRAND          56..60
FT                   /evidence="ECO:0007744|PDB:1WJL"
FT   HELIX           62..71
FT                   /evidence="ECO:0007744|PDB:1WJL"
FT   STRAND          74..81
FT                   /evidence="ECO:0007744|PDB:1WJL"
FT   MOD_RES         Q9JKS4-2:112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CONFLICT        Q9JKS4-2:176..188
FT                   /note="AQGSDFSGASPLA -> AQGSDFSG (in Ref. 4; AAO26189)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q9JKS4-3:330
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         Q9JKS4-4:112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         Q9JKS4-4:291
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         Q9JKS4-5:327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         Q9JKS4-6:112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         Q9JKS4-6:288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
SQ   SEQUENCE   723 AA;  76432 MW;  CC67D38AC2FFA6B6 CRC64;
     MSYSVTLTGP GPWGFRLQGG KDFNMPLTIS RITPGSKAAQ SQLSQGDLVV AIDGVNTDTM
     THLEAQNKIK SASYNLSLTL QKSKRPIPIS TTAPPIQSPL PVIPHQKDPA LDTNGSLATP
     SPSPEARASP GALEFGDTFS SSFSQTSVCS PLMEASGPVL PLGSPVAKAS SEGAQGSVSP
     KVLPGPSQPR QYNNPIGLYS AETLREMAQM YQMSLRGKAS GAGLLGGSLP VKDLAVDSAS
     PVYQAVIKTQ SKPEDEADEW ARRSSNLQSR SFRILAQMTG TEYMQDPDEE ALRRSSTPIE
     HAPVCTSQAT SPLLPASAQS PAAASPIAAS PTLATAAATH AAAASAAGPA ASPVENPRPQ
     ASAYSPAAAA SPAPSAHTSY SEGPAAPAPK PRVVTTASIR PSVYQPVPAS SYSPSPGANY
     SPTPYTPSPA PAYTPSPAPT YTPSPAPTYS PSPAPAYTPS PAPNYTPTPS AAYSGGPSES
     ASRPPWVTDD SFSQKFAPGK STTTVSKQTL PRGAPAYNPT GPQVTPLARG TFQRAERFPA
     SSRTPLCGHC NNVIRGPFLV AMGRSWHPEE FNCAYCKTSL ADVCFVEEQN NVYCERCYEQ
     FFAPICAKCN TKIMGEVMHA LRQTWHTTCF VCAACKKPFG NSLFHMEDGE PYCEKDYINL
     FSTKCHGCDF PVEAGDKFIE ALGHTWHDTC FICAVCHVNL EGQPFYSKKD KPLCKKHAHA
     INV
//
